Highlights Morepen Laboratories Limited

Equities

MOREPENLAB

INE083A01026

Market Closed - Bombay S.E. Other stock markets 03:00:37 2024-05-18 am EDT			5-day change	1st Jan Change
47.87 ^INR	+2.11%		+4.98%	-1.36%

Mar. 30	Morepen Laboratories Limited Announces Resignation of Lalit Kumar Baregama, Chief Growth Officer	CI
Mar. 01	Morepen Laboratories Limited Announces the Promotion of Amita Sharma to Chief Operating Officer -API	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Morepen Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Jan. 31	CI
Morepen Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 02	CI
Morepen Laboratories to Transfer Formulation Distribution and Marketing Business to Subsidiary	23-08-15	MT
Morepen Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-05	CI
Morepen Laboratories' Net Profit Drops in Fiscal Q4	23-05-16	MT
Morepen Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-16	CI
US FDA Clears Morepen Laboratories' Baddi, India	23-03-27	MT
Morepen Laboratories Forms Wholly-Owned Subsidiary	23-03-20	MT
Morepen Laboratories Limited Announces Incorporation of Wholly Owned Subsidiary	23-03-17	CI
Morepen Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-13	CI
Morepen Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-10	CI
Morepen Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	22-07-29	CI
Morepen Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022	22-05-05	CI
Morepen Laboratories Sees Drop in Fiscal Q4 Consolidated Net Profit	22-05-05	MT
Morepen Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2022	22-05-05	CI
Morepen Laboratories Posts Decline in Fiscal Q3 Consolidated Net Profit	22-02-09	MT
Morepen Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	22-02-08	CI
Morepen Gets USFDA Approval for Fexofinadine	21-12-03	CI
Morepen Laboratories Clocks 38% Jump in Fiscal Q2 Consolidated Profit	21-11-12	MT
Morepen Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	21-11-11	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Morepen Laboratories Limited

Equities

MOREPENLAB

INE083A01026

Highlights

Filters